Novartis Ag Adr Stock Price on November 21, 2024
| NVS Stock | USD 104.28 0.43 0.41% |
Below is the normalized historical share price chart for Novartis AG ADR extending back to May 11, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novartis stands at 104.28, as last reported on the 22nd of November, with the highest price reaching 105.19 and the lowest price hitting 104.18 during the day.
If you're considering investing in Novartis Stock, it is important to understand the factors that can impact its price. Novartis AG ADR has Sharpe Ratio of -0.21, which conveys that the firm had a -0.21% return per unit of risk over the last 3 months. Novartis exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novartis' Mean Deviation of 0.6822, risk adjusted performance of (0.14), and Standard Deviation of 0.9711 to check out the risk estimate we provide.
At this time, Novartis' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 103.1 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 776.8 M in 2024. . At this time, Novartis' Price Earnings Ratio is comparatively stable compared to the past year. Price To Operating Cash Flows Ratio is likely to gain to 15.77 in 2024, whereas Price Book Value Ratio is likely to drop 3.23 in 2024. Novartis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of November 1991 | 200 Day MA 106.4505 | 50 Day MA 112.3322 | Beta 0.505 |
Novartis |
Sharpe Ratio = -0.2077
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVS |
Estimated Market Risk
| 0.98 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novartis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novartis by adding Novartis to a well-diversified portfolio.
Price Book 4.7931 | Enterprise Value Ebitda 11.4302 | Price Sales 4.1575 | Shares Float 1.9 B | Dividend Share 3.919 |
Novartis Main Headline on 21st of November 2024
Why Is Legend Biotech Corporation Among the Worst Performing... by finance.yahoo.com
We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Legend Biotech Corporation stands against the other biotech stocks. Biotechnology Stocks Navigating Volatility Amid Market Fluctuations and Industry Growth Biotechnology stocks are among the most volatile in the market
Novartis Valuation on November 21, 2024
It is possible to determine the worth of Novartis on a given historical date. On November 21, 2024 Novartis was worth 103.16 at the beginning of the trading date compared to the closed value of 103.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novartis stock. Still, in general, we apply an absolute valuation method to find Novartis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novartis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novartis' related companies.
| Open | High | Low | Close | Volume | |
| 102.80 | 103.19 | 102.46 | 103.09 | 1,059,764 | |
11/21/2024 | 103.16 | 103.93 | 103.03 | 103.85 | 1,527,943 |
| 104.44 | 105.19 | 104.18 | 104.28 | 1,337,231 |
| Backtest Novartis | | | Novartis History | | | Novartis Valuation | Previous | Next |
Novartis Trading Date Momentum on November 21, 2024
| On November 22 2024 Novartis AG ADR was traded for 104.28 at the closing time. Highest Novartis's price during the trading hours was 105.19 and the lowest price during the day was 104.18 . The net volume was 1.3 M. The overall trading history on the 22nd of November contributed to the next trading period price appreciation. The trading delta at closing time to the next next day price was 0.41% . The trading delta at closing time to current price is 0.57% . |
Novartis AG ADR Fundamentals Correlations and Trends
By evaluating Novartis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novartis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novartis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novartis Stock history
Novartis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novartis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novartis AG ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novartis stock prices may prove useful in developing a viable investing in Novartis
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.1 B | 1.9 B | |
| Net Income Applicable To Common Shares | 8 B | 9.8 B |
Novartis Stock Technical Analysis
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novartis Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Novartis AG ADR cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Novartis November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Novartis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novartis shares will generate the highest return on investment. By undertsting and applying Novartis stock market strength indicators, traders can identify Novartis AG ADR entry and exit signals to maximize returns
Novartis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novartis' price direction in advance. Along with the technical and fundamental analysis of Novartis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novartis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | (0.97) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.